SCHEMBL8360854

SCHEMBL8360854

O=C(c1ccccc1)c1cncc2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 5/20 0.38
MAPK13 O15264 2/20 0.37
MAPK12 P53778 2/20 0.37
MAPK11 Q15759 2/20 0.37
GAA P10253 2/20 0.37
GFER P55789 1/20 0.37
MAPT P10636 3/20 0.36
ABL1 P00519 1/20 0.35
SRC P12931 1/20 0.35
MAPK1 P28482 2/20 0.34
HPGD P15428 2/20 0.34
PSMB5 P28074 1/20 0.34
PDE11A Q9HCR9 1/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HTT P42858 2/20 0.33
ALDH1A1 P00352 2/20 0.33
LMNA P02545 2/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287991 0.90 GAA (0.39) GAAGFERMAPTMAPK1HPGD
SCHEMBL8287257 0.87 RAB9A (0.40) GAAMAPTMAPK1HPGDNPC1
SCHEMBL8362709 0.85 PDE11A (0.39) GAAGFERMAPTMAPK1HPGD
SCHEMBL8287252 0.85 CXCR2 (0.37) GAAGFERMAPTMAPK1HPGD
SCHEMBL8287253 0.84 RIPK1 (0.43) MAPK14MAPTNPC1RAB9AHTT
SCHEMBL8287988 0.82 CSF1R (0.47) GAAMAPTHPGDSMN1; SMN2HTT
SCHEMBL8287258 0.82 GRM5 (0.45) GAAMAPTMAPK1HPGDSMN1; SMN2
SCHEMBL8360822 0.81 CSF1R (0.37) MAPK14MAPTHPGDPDE11ASMN1; SMN2
SCHEMBL8287246 0.81 GAA (0.39) GAAGFERMAPTSRCMAPK1
SCHEMBL8285367 0.81 KCNJ6 (0.37) MAPK14MAPK13MAPK12MAPK11GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed